Clinical Trial Update: Safety, Tolerability and Pharmacodynamics Evaluation of CBT-009 Eye Drop [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update on safety, tolerability, and pharmacodynamics of CBT-009 eye drops for progressive myopia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia
• Progressive Myopia

Drugs mentioned

• CBT-009

Snippet

Sponsor: Cloudbreak Therapeutics, LLC | Conditions: Myopia, Progressive | Phase 1, Phase 2 | Status: COMPLETED